Notably, there were no significant interactions observed between PIK3CA mutation status, BC subtype, and prognosis with the exception of HER2 disease and OS IDFS P <a href=http://clomid.buzz>whats clomid used for Postmenopausal women with ER positive and or PgR positive locally advanced or metastatic breast cancer who had not received any prior endocrine therapy for locally advanced or metastatic disease